Royalty Adjustments. The following adjustments will be made, on a Product-by-Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.1:
Appears in 3 contracts
Samples: And License Agreement (BioNTech SE), And License Agreement (BioNTech SE), Research Collaboration and License Agreement (Locust Walk Acquisition Corp.)
Royalty Adjustments. The following adjustments will shall be made, on a Product-by-Product and countryProduct, jurisdiction-by-country jurisdiction and Territory-wide basis, to the royalties payable pursuant to Section 3.5.13.3.1:
Appears in 2 contracts
Samples: License Agreement, License Agreement (Capstone Therapeutics Corp.)
Royalty Adjustments. The following adjustments will shall be made, on a Product-by-Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.1, in each case, subject to the limitations set forth in Section 3.5.4:
Appears in 2 contracts
Samples: License Agreement (Palatin Technologies Inc), License Agreement (Amag Pharmaceuticals Inc.)
Royalty Adjustments. The following adjustments will be made, on a Product-by-Product and country-by-country basis, to the royalties royalty payable pursuant to Section 3.5.18.3.1:
Appears in 1 contract
Samples: Collaboration and License Agreement (Myovant Sciences Ltd.)
Royalty Adjustments. The following adjustments will be made, on a Product-by-Product by -Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.13.4.1:
Appears in 1 contract
Royalty Adjustments. The following adjustments will shall be made, on a Product-by-Product and countryJurisdiction-by-country Jurisdiction basis, to the royalties payable pursuant to Section 3.5.13.4.1, in each case, subject to the limitations set forth in Section 3.4.4:
Appears in 1 contract
Royalty Adjustments. The following adjustments will shall be made, on a Product-by-Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.1:3.6: *Confidential Treatment Requested. 4
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Pharmathene, Inc)
Royalty Adjustments. The following adjustments will shall be made, on a Product-by-Product and countryProduct, Country-by-country Country and Region-by-Region basis, to the royalties payable pursuant to Section 3.5.1:7.3, provided that in no event shall the aggregate [***].
Appears in 1 contract
Royalty Adjustments. The following adjustments will be made, on a Licensed Product-by-Licensed Product and country-by-country basis, to the royalties royalty payable pursuant to Section 3.5.1:3.5 (Royalties):
Appears in 1 contract
Samples: Sublicense Agreement (Biohaven Pharmaceutical Holding Co Ltd.)
Royalty Adjustments. The following adjustments will be made, on a Product-by-Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.13.4.1:
Appears in 1 contract
Royalty Adjustments. The following adjustments will shall be made, on a Licensed Product-by-Licensed Product and country-by-country basis, to the royalties payable pursuant to Section 3.5.13.3.1, in the following order:
Appears in 1 contract
Samples: License Agreement (Repligen Corp)
